ERBB2 and breast carcinoma: A statistically significant increase in 8-OHdG concentration was shown in HER2-positive breast cancer, namely for the luminal B(+) (+47.1%, p = 0.0419) and non-luminal subtypes (+153.5%, p = 0.0167) (Supplementary Table S1).